FARMASINTEZ, JSC (Irkutsk) ,   Russia

Film-coated tablets, 300 mg + 300 mg + 150 mg.

Film-coated tablets, 600 mg + 300 mg.

Film coated tablets, 200 mg, 400 mg and 600 mg.

Film-coated tablets, 300 mg.

Liofilizate for the preparation of solution for infusions 13.49 g.

Solution for intravenous administration, 400 mg / ml.

The tablets covered with a film cover, 300 mg + 200 mg.

Tablets, film-coated, 200 mg, 400 mg.

Tablets coated with enteric film coating, 1,145 g + 0,0333 g.

Tablets, film-coated, 100 mg + 25 mg, 200 mg + 50 mg.

Concentrate for the preparation of solution for infusion.

Capsules of 125 mg, 250 mg and 500 mg.

Tablets, film-coated, 800 mg.

Tablets, film-coated, 75 mg, 150 mg, 300 mg, 400 mg, 600 mg.

Capsules 5 mg, 10 mg, 15 mg, 25 mg.

Tablets, film-coated, 400 mg.

Granules coated with enteric coating 600 mg / g.

Solution for injection 0.9%.

Primary packaging. To 2, 5, 10 ml into polyethylene polyethylene of low density brand "Purell PE 3020 D" firms "Basell Sales & Marketing Company B.V." (Netherlands), or brands "Seetec BB120 "company "LG Chem" (South Korea), or from polyethylene for infusion and injection preparations in accordance with the requirements of the European Pharmacopoeia of the current edition.

On ampoules paste labels from paper label, writing, for printing offset or imported.

Secondary packaging. For 5 or 10 ampoules connected in cassettes with instructions for use are placed in a pack of cardboard for consumer packaging subgroups chrome or chromium-ersatz or other similar quality. The packets are placed in a shipping container.

Tablets, film-coated, 100 mg and 200 mg each.

Capsules, 30 mg, 45 mg and 75 mg.

Tablets, film-coated, 200 mg.

Tablets coated with an enteric coating containing an active ingredient of 500 mg or 1000 mg.

Tablets, film-coated, 250 mg.

Tablets coated with a film coat, 135 mg + 200 mg + 370 mg + 325 mg + 10 mg and 135 mg + 200 mg + 370 mg + 325 mg + 15 mg

Tablets, 150 mg + 500 mg and 300 mg + 750 mg.

Tablets, film-coated 600 mg + 25 mg + 75 mg + 15 mg.

Tablets, 150 mg + 400 mg and 300 mg + 800 mg.

Capsules, 150 mg, 200 mg and 300 mg.

Film-coated tablets, 150 mg and 300 mg Primary packaging of medicinal product.

For 10 tablets, coated with a film sheath, into a contoured cell packaging made of a polyvinylchloride film and aluminum foil printed lacquered.

For 30, 60, 100, 500 or 1000 tablets, film-coated in a polymer can with a lid pulled with the control of the first opening. Free space is filled with cotton wool. Labels are applied to cans from paper label or writing paper, or from polymer materials, self-adhesive.

Secondary packaging of medicinal product.

For 3, 6 or 10 contour mesh packages together with the instructions for use are placed in a pack of cardboard for consumer packaging subgroups chrome or chrome - ersatz or other similar quality. The packets are placed in a shipping container.

One bank along with instructions for use is placed in a pack of cardboard for consumer packaging subgroups chrome or chrome - ersatz or other similar quality. The packets are placed in a shipping container.

Tablets are enteric, coated with 1500 mg.

Tablets, film-coated, 0.5 and 1.0 mg.

Tablets, film-coated, 200 mg

Tablets, 400 mg.

Tablets 150 mg.